Literature DB >> 1712073

Presentation of insulin and insulin A chain peptides to mouse T cells: involvement of cysteine residues.

J Hampl1, G Gradehandt, D Plachov, H G Gattner, H Kalbacher, W Voelter, M Meyer-Delius, E Rüde.   

Abstract

The requirements for insulin presentation and recognition by A alpha b A beta b- and A alpha b A beta k-restricted mouse T cells were studied using a variety of derivatives of the insulin A chain. It was found that A chain peptides with irreversibly blocked Cys residues are non-stimulatory for the T cells. This suggests that at least one of the Cys residues is essential for recognition. On the other hand, all A chain peptides containing Cys residues modified in a way reversible by reaction with thiols are stimulatory yet differ in antigenic potency. All these A chain derivatives including a 14 amino acid fragment require uptake by antigen presenting cells (APC) for efficient presentation. Differences in stimulatory potency between the A chain peptides derived from the same insulin appear to be mainly due to the efficiency of uptake and/or processing by APC. Based on these findings we propose that processing in the case of insulin and its A chain derivatives involves the reductive deblocking of Cys residues or the rearrangement of disulfide bonds apart from a possible proteolytic cleavage. The same may apply to other proteins if Cys residues in the presented peptides are important for the interaction with Ia or the T cell receptor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712073     DOI: 10.1016/0161-5890(91)90162-d

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  2 in total

1.  The endo/lysosomal protease cathepsin B is able to process conalbumin fragments for presentation to T cells.

Authors:  G Gradehandt; E Ruede
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

2.  Importance of thioredoxin in the proteolysis of an immunoglobulin G as antigen by lysosomal Cys-proteases.

Authors:  I Kerblat; C Drouet; S Chesne; P N Marche
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.